{"schema_version":"secwatch.filing_event.v1","accession":"0001824293-23-000142","form_type":"8-K","ticker":"GRI","cik":"0001824293","company_name":"GRI Bio, Inc.","filed_at":"2023-07-07T23:59:59+00:00","discovered_at":"2026-05-14T18:03:35.481371+00:00","generated_at":"2026-06-13T11:12:51.703696+00:00","sec_items":["5.07"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.15,"calibrated_materiality_score":0.15,"confidence":"high","headline":"GRI Bio annual meeting elects two directors, ratifies auditor","bullets":["Directors W. Marc Hertz and David Szekeres elected with over 1.06M votes for each as Class III directors.","Ratification of Sadler, Gibb & Associates as independent auditor approved with 1,169,668 votes for.","Annual meeting held virtually on July 7, 2023; quorum of 1,172,148 shares (40.16%) present."],"urls":{"canonical":"https://secwatch.observer/filing/0001824293-23-000142","json":"https://secwatch.observer/filing/0001824293-23-000142.json","markdown":"https://secwatch.observer/filing/0001824293-23-000142.md","text":"https://secwatch.observer/filing/0001824293-23-000142.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1824293/000182429323000142/0001824293-23-000142-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1824293/000182429323000142/val-20230707.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-13T11:12:51.703696+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"0ccd563bf7df555e1d34b8eb146bd3b51a8e7d00","claim":"GRI Bio, Inc. shareholders approved Ratification of the appointment of Sadler, Gibb & Associates LLC as the Company’s independent registered public accounting firm for the year ending December 31, 2023 at the 2023-07-07 meeting.","evidence_excerpt":"Proposal 2 Ratification of the appointment of Sadler, Gibb & Associates LLC as the Company’s independent registered public accounting firm for the year ending December 31, 2023. Votes For Votes Against Votes Abstained 1,169,668 1,957 523","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1824293/000182429323000142/0001824293-23-000142-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"auditor ratification"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2023-07-07"}],"fact_type":"shareholder_vote"},{"claim_id":"5536a67eb4d65259677396b1a171f0bf8ac45c2d","claim":"GRI Bio, Inc. shareholders approved Election of the following nominees as directors of the Company, each to serve as Class III directors until the Company’s 2026 Annual Meeting at the 2023-07-07 meeting.","evidence_excerpt":"Proposal 1 Election of the following nominees as directors of the Company, each to serve as Class III directors until the Company’s 2026 Annual Meeting and until his successor is duly elected and qualified. Votes For Votes Against Votes Abstained Broker Non-Votes W. Marc Hertz, Ph.D. 1,068,309 1,845 335 101,659 David Szekeres 1,068,073 1,926 490 101,659","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1824293/000182429323000142/0001824293-23-000142-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"director election"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2023-07-07"}],"fact_type":"shareholder_vote"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}